Kymera Therapeutics, Inc.

The current price of KYMR is 35.21 USD — it has decreased by 1.40% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Kymera Therapeutics, Inc. stocks are traded under the ticker KYMR.

Kymera Therapeutics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

KYMR stock is 5.19% volatile and has beta coefficient of 3.23. Check out the list of the most volatile stocks — is Kymera Therapeutics, Inc. there?

KYMR earnings for the last quarter are −0.90 USD per share, whereas the estimation was −0.64 USD resulting in a −41.33% surprise. The estimated earnings for the next quarter are −0.40 USD per share. See more details about Kymera Therapeutics, Inc. earnings.

Kymera Therapeutics, Inc. revenue for the last quarter amounts to ‪4.73 M‬ USD despite the estimated figure of ‪15.97 M‬ USD. In the next quarter revenue is expected to reach ‪41.94 M‬ USD.

Yes, you can track Kymera Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

KYMR stock has risen by 2.38% compared to the previous week, the month change is a 13.34% fall, over the last year Kymera Therapeutics, Inc. has showed a 7.31% increase.

Today Kymera Therapeutics, Inc. has the market capitalization of ‪2.18 B‬, it has increased by 1.24% over the last week.

No, KYMR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, KYMR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kymera Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

KYMR reached its all-time high on Dec 28, 2020 with the price of 91.92 USD, and its all-time low was 9.60 USD and was reached on Nov 2, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 187.00 employees. See our rating of the largest employees — is Kymera Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kymera Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kymera Therapeutics, Inc. stock shows the buy signal. See more of Kymera Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Kymera Therapeutics, Inc. future price: according to them, KYMR price has a max estimate of 112.00 USD and a min estimate of 30.00 USD. Read a more detailed Kymera Therapeutics, Inc. forecast: see what analysts think of Kymera Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kymera Therapeutics, Inc. EBITDA is ‪−161.97 M‬ USD, and current EBITDA margin is −206.08%. See more stats in Kymera Therapeutics, Inc. financial statements.